eMedicine Specialties > Pediatrics: General Medicine > Gastroenterology

Protein Intolerance: Differential Diagnoses & Workup

Author: Agostino Nocerino, MD, PhD, Chief of Pediatric Oncology, Department of Pediatrics, University of Udine, Italy
Coauthor(s): Stefano Guandalini, MD, Director, University of Chicago Celiac Disease Program, Section Chief of Gastroenterology, Hepatology and Nutrition; Professor, Department of Pediatrics, University of Chicago Comer Children's Hospital
Contributor Information and Disclosures

Updated: Aug 25, 2009

Differential Diagnoses

Crohn Disease
Gastroenteritis
Gastroesophageal Reflux
Ulcerative Colitis

Other Problems to Be Considered

Enteropathy
Celiac disease
Autoimmune enteropathy
Intractable diarrhea of infancy
Intestinal infections

Enterocolitis syndrome
Intestinal infections
Inflammatory bowel diseases

Proctocolitis
Anal fissures
Meckel diverticulum
Intestinal duplication
Intestinal hemangiomas
Intestinal infections
Inflammatory bowel disease

Workup

Laboratory Studies

The following tests are indicated in assessing food protein intolerance:

  • Radioallergosorbent test (RAST): RAST is often used to screen for antigen-specific IgE in the patient's serum.
  • Enzyme-linked immunosorbent assay (ELISA): ELISAs have been replacing methods that use radiation. Unfortunately, determination of specific IgE involves the same problems as the skin test. A negative test result has a high predictive accuracy with a low sensitivity, whereas a positive test result has a low predictive value.
  • Fecal leukocytes: Fecal eosinophils are a significant clue to the diagnosis of allergic colitis. However, although eosinophils predominate after a single acute challenge, the findings on fecal smears at diagnosis are more likely of the inflammatory type, with a predominant population of lymphocytes and neutrophils and a small number of eosinophils.
  • Allergic eosinophilic esophagitis
    • Total serum IgE is within the reference range or slightly elevated.
    • Peripheral eosinophilia is uncommon.
    • Skin test and RAST results are frequently negative.
    • Results of pH testing can be pathologic or normal.
    • Esophageal biopsy reveals infiltration of the mucosa and submucosa with eosinophils.
  • Allergic eosinophilic gastritis
    • The IgE level is elevated in approximately half of patients.
    • Peripheral eosinophilia is present in approximately half of patients.
    • Gastric biopsy findings reveal marked infiltration of the mucosa and submucosa with eosinophils (especially in the gastric antrum).
  • Allergic eosinophilic gastroenteritis
    • Peripheral eosinophilia is commonly found but is not reliable as a diagnostic criterion.
    • Diagnosis requires a biopsy specimen showing an eosinophilic infiltration of the mucosa and submucosa.
    • Unfortunately, no standards for making the histologic diagnosis are recognized. In infants and children without GI symptoms, eosinophilic counts in the gastric fundus and antrum are consistently low, but in the terminal ileum, cecum, and proximal colon, an eosinophil count as high as 30 per high-power field can be detected.
  • Immediate GI hypersensitivity
    • Prick tests and RAST results are usually positive.
    • Fluoroscopy studies show gastric hypotonia, prominent pylorospasm, and subsequent increased or decreased peristaltic activity of the intestine.
  • Enterocolitis syndrome
    • Prick tests and RAST results are usually negative.
    • Stools generally contain occult blood, neutrophils, and eosinophils. The jejunal biopsy findings reveal villous atrophy and infiltration by lymphocytes, eosinophils, and mast cells.
  • Nonceliac food-induced enteropathy
    • The results of both IgE-specific tests (ie, prick, RAST) are usually normal.
    • The findings of the jejunal biopsy are similar to those in celiac disease but usually are less pronounced. A varying degree of villous atrophy is present, with crypt hyperplasia and lymphocytic infiltration of the lamina propria. Often, the lesions have a patchy distribution, observed especially in the last few years. Several studies have detected increased numbers of IgE plasmocytes in biopsy specimens of patients with cow's milk protein intolerance.
  • Food-induced proctitis
    • Fecal leukocytes are usually positive for neutrophils.
    • Eosinophils can be absent.
    • For colonoscopic findings, see Procedures.

Other Tests

  • Skin test responses to cow's milk or other food proteins and detection of food-specific IgE antibodies are usually positive in children with IgE-mediated food allergy. However, most of the food protein intolerances are not IgE-mediated. A double-blind placebo-controlled oral food challenge is the ideal method for definitely confirming histories of adverse reactions to food proteins. However, this approach is rarely used in clinical practice. In addition, even double-blind placebo-controlled challenges can have pitfalls.
  • Skin testing with food extracts is often used to screen patients with suspected IgE-mediated food allergies.
    • Skin testing is usually completed by the prick technique, which is a reliable means of detecting IgE antibodies to food in children.
    • A positive skin test result merely implies the presence of food-specific IgE antibodies. A negative skin test result has a high predictive accuracy (estimated to be >95%).
    • Unfortunately, a positive prick test result is a poor predictor of clinical symptoms during food challenges. The positive predictive accuracy widely varies but has been estimated to be lower than 50%. In children younger than 2 years, the negative predictive accuracy of the skin test result is not as good as in older children, but, on the other hand, a positive test result is more likely to be significant. Composition and quality of the extracts are also a significant consideration. Sometimes, testing a drop of the milk that is used to feed the child (eg, formula milk, soy milk, others) is preferable.
  • A position statement issued by the American Academy of Allergy, Asthma, and Immunology considered cytotoxic testing, provocative subcutaneous testing, and provocative sublingual tests to be of unproven value.
  • Elimination diets involve the following:
    • The simplest type of elimination diet is elimination of suspected food antigens from the diet for 2-4 weeks or longer.
    • When no specific allergens can be incriminated, the common food allergens are eliminated from the diet.
    • In severe and unresponsive cases, consider the use of an elemental diet.
  • Food challenge tests involve the following:
    • An elimination diet for 10-14 days should precede a food challenge test.
    • Perform a food challenge under medical supervision. A history of food-related anaphylaxis is a relative contraindication to food challenge.
    • An open food challenge (both the physician and the patient are aware of the food) can be accepted when the resulting symptoms can be objectively observed. Use a double-blind placebo-controlled food challenge (both the physician and the patient are unaware of the food) if the resulting symptoms are only subjective.
    • The oral food challenge has been established as the criterion standard for the diagnosis of adverse food reactions caused by any mechanism. The test is diagnostic of food intolerance when symptoms subside following dietary elimination of the offending food or when symptoms recur within 48 hours after milk provocation. Reactions must be reproducible with repeated elimination/challenge tests. Delayed-onset reactions, a common cause of GI reactions, cause symptoms hours or days after the ingestion, with a timing pattern. In cow's milk protein intolerance, the same original clinical picture tends to recur after the challenge.
    • Very delayed clinical reactions to food challenge including constipation, wheezing, dermatitis plus constipation, and dermatitis alone have been reported in a small subgroup of patients. The mean time between the challenge and the onset of a clinical symptom was 13.3 days (range, 4-26 d).

Procedures

  • Upper and lower GI endoscopies: Usually, the clinical picture and the history are clear, and the recommended diagnostic process (see Lab Studies above) does not require performance of endoscopic procedures. However, endoscopy may be part of the differential diagnostic workup in cases in which clinical doubt is acknowledged.
    • Upper endoscopy
      • In cases with eosinophilic esophagitis, various degrees of hyperemia are macroscopically observed. In addition, furrowing of the mucosa, rings, and plaques have been described. Microscopically, eosinophils are observed infiltrating the esophageal wall. Although no pathognomonic histologic characteristics are associated with eosinophilic esophagitis, an eosinophilic count of more than 20 cells per high-power field is considered diagnostic of this recently described entity. Patchy lymphonodular hyperplasia of the GI tract, at any site from the duodenum to the colon, has been suggested to be related to food allergy.
      • In patients presenting with signs or symptoms of enteropathy, an upper endoscopy with duodenal biopsies may be indicated in the diagnostic workup. The microscopic picture of enteropathy can totally overlap with that of celiac disease (ie, partial to total villous atrophy, crypt hyperplasia), possibly with a more common occurrence of a patchy lesion rather than continuous lesion.
    • Lower GI endoscopy (colonoscopy): This procedure is completed in the presence of signs or symptoms of colitis or proctitis (mainly lower GI bleeding) and whenever the diagnosis of food-induced colitis is not obvious. In food-induced colitis, the procedure macroscopically reveals linear erosions and mucosal edema. Bowel lesions are generally confined to the distal large bowel. Microscopically, focal erythema and frequent nodularity with superficial erosions are observed. Eosinophilic infiltration, most prominent in the lamina propria, can be observed in the biopsy specimens but is by no means a constant finding.
  • Biopsy
    • In allergic eosinophilic esophagitis, esophageal biopsy reveals infiltration of the mucosa and submucosa with eosinophils.
    • In allergic eosinophilic gastritis, gastric biopsy reveals marked infiltration of the mucosa and submucosa with eosinophils (especially in the gastric antrum).
    • In allergic eosinophilic gastroenteritis, diagnosis requires a biopsy specimen that reveals an eosinophilic infiltration of the mucosa and submucosa. Unfortunately, no standards for making the histologic diagnosis are available. In infants and children without GI symptoms, eosinophilic counts in the gastric fundus and antrum are consistently low, but in the terminal ileum, cecum, and proximal colon, eosinophil counts as high as 30 per high-power field can be detected.
    • In enterocolitis syndrome, the jejunal biopsy reveals villous atrophy and infiltration by lymphocytes, eosinophils, and mast cells.
    • In nonceliac food-induced enteropathy, the findings of the jejunal biopsy are similar to those in celiac disease but usually are less pronounced. A varying degree of villous atrophy is present with crypt hyperplasia and lymphocytic infiltration of the lamina propria. Often, the lesions have a patchy distribution, observed especially in the last few years. Several studies have detected increased numbers of IgE plasmocytes in biopsy specimens of patients with cow's milk protein intolerance.

Histologic Findings

See Procedures.

More on Protein Intolerance

Overview: Protein Intolerance
Differential Diagnoses & Workup: Protein Intolerance
Treatment & Medication: Protein Intolerance
Follow-up: Protein Intolerance
Multimedia: Protein Intolerance
References

References

  1. Branum AM, Lukacs SL. Food allergy among U.S. children: trends in prevalence and hospitalizations. NCHS Data Brief. Oct 2008;(10):1-8. [Medline].

  2. Assa'ad A. Eosinophilic gastrointestinal disorders. Allergy Asthma Proc. Jan-Feb 2009;30(1):17-22. [Medline].

  3. Hill DJ, Hosking CS, Heine RG. Clinical spectrum of food allergy in children in Australia and South-East Asia: identification and targets for treatment. Ann Med. Aug 1999;31(4):272-81. [Medline].

  4. Colver AF, Nevantaus H, Macdougall CF, Cant AJ. Severe food-allergic reactions in children across the UK and Ireland, 1998-2000. Acta Paediatr. Jun 2005;94(6):689-95. [Medline].

  5. [Best Evidence] Kvenshagen B, Jacobsen M, Halvorsen R. Atopic dermatitis in premature and term children. Arch Dis Child. Mar 2009;94(3):202-5. [Medline].

  6. Ozdemir O, Mete E, Catal F, Ozol D. Food intolerances and eosinophilic esophagitis in childhood. Dig Dis Sci. Jan 2009;54(1):8-14. [Medline].

  7. Mehr SS, Kakakios AM, Kemp AS. Rice: a common and severe cause of food protein-induced enterocolitis syndrome. Arch Dis Child. Mar 2009;94(3):220-3. [Medline].

  8. Host A, Halken S, Jacobsen HP, Christensen AE, Herskind AM, Plesner K. Clinical course of cow's milk protein allergy/intolerance and atopic diseases in childhood. Pediatr Allergy Immunol. 2002;13 Suppl 15:23-8. [Medline].

  9. Kokkonen J, Tikkanen S, Karttunen TJ, Savilahti E. A similar high level of immunoglobulin A and immunoglobulin G class milk antibodies and increment of local lymphoid tissue on the duodenal mucosa in subjects with cow's milk allergy and recurrent abdominal pains. Pediatr Allergy Immunol. Apr 2002;13(2):129-36. [Medline].

  10. Walker WA. Cow's milk protein-sensitive enteropathy at school age: a new entity or a spectrum of mucosal immune responses with age. J Pediatr. Dec 2001;139(6):765-6. [Medline].

  11. Iacono G, Cavataio F, Montalto G, et al. Intolerance of cow's milk and chronic constipation in children. N Engl J Med. Oct 15 1998;339(16):1100-4. [Medline].

  12. Lack G. Clinical practice. Food allergy. N Engl J Med. Sep 18 2008;359(12):1252-60. [Medline].

  13. Kull I, Bergstrom A, Lilja G, Pershagen G, Wickman M. Fish consumption during the first year of life and development of allergic diseases during childhood. Allergy. Aug 2006;61(8):1009-15. [Medline].

  14. [Guideline] Greer FR, Sicherer SH, Burks AW. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. Jan 2008;121(1):183-91. [Medline].

  15. Iacono G, Di Prima L, D'Amico D, Scalici C, Geraci G, Carroccio A. The "red umbilicus": a diagnostic sign of cow's milk protein intolerance. J Pediatr Gastroenterol Nutr. May 2006;42(5):531-4. [Medline].

  16. Foucard T, Malmheden Yman I. A study on severe food reactions in Sweden--is soy protein an underestimated cause of food anaphylaxis?. Allergy. Mar 1999;54(3):261-5. [Medline].

  17. [Best Evidence] Osborn DA, Sinn J. Soy formula for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev. Oct 18 2006;CD003741. [Medline].

  18. Axelsson I, Jakobsson I, Lindberg T, Benediktsson B. Bovine beta-lactoglobulin in the human milk. A longitudinal study during the whole lactation period. Acta Paediatr Scand. Sep 1986;75(5):702-7. [Medline].

  19. Blackshaw AJ, Levison DA. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol. Jan 1986;39(1):1-7. [Medline].

  20. Bock SA. Evaluation of IgE-mediated food hypersensitivities. J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S20-7. [Medline].

  21. Carroccio A, Montalto G, Custro N, et al. Evidence of very delayed clinical reactions to cow's milk in cow's milk-intolerant patients. Allergy. Jun 2000;55(6):574-9. [Medline].

  22. Dupont C, Heyman M. Food protein-induced enterocolitis syndrome: laboratory perspectives. J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S50-7. [Medline].

  23. Hill DJ, Firer MA, Shelton MJ, Hosking CS. Manifestations of milk allergy in infancy: clinical and immunologic findings. J Pediatr. Aug 1986;109(2):270-6. [Medline].

  24. Hill DJ, Heine RG, Cameron DJ, Francis DE, Bines JE. The natural history of intolerance to soy and extensively hydrolyzed formula in infants with multiple food protein intolerance. J Pediatr. Jul 1999;135(1):118-21. [Medline].

  25. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. Apr 2007;119(4):1019-21. [Medline].

  26. Kelly KJ. Eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S28-35. [Medline].

  27. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. Nov 1995;109(5):1503-12. [Medline].

  28. Kokkonen J, Haapalahti M, Laurila K, Karttunen TJ, Maki M. Cow's milk protein-sensitive enteropathy at school age. J Pediatr. Dec 2001;139(6):797-803. [Medline].

  29. Kokkonen J, Karttunen TJ, Niinimäki A. Lymphonodular hyperplasia as a sign of food allergy in children. J Pediatr Gastroenterol Nutr. Jul 1999;29(1):57-62. [Medline].

  30. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. Jan 2007;119(1):192-8. [Medline].

  31. Lake AM. Food-induced eosinophilic proctocolitis. J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S58-60. [Medline].

  32. Lake AM, Whitington PF, Hamilton SR. Dietary protein-induced colitis in breast-fed infants. J Pediatr. Dec 1982;101(6):906-10. [Medline].

  33. Leung AK. Food allergy: a clinical approach. Adv Pediatr. 1998;45:145-77. [Medline].

  34. Liacouras CA, Ruchelli E. Eosinophilic esophagitis. Curr Opin Pediatr. Oct 2004;16(5):560-6. [Medline].

  35. Lindberg T. Infantile colic: aetiology and prognosis. Acta Paediatr. Jan 2000;89(1):1-2. [Medline].

  36. Lowichik A, Weinberg AG. A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract. Mod Pathol. Feb 1996;9(2):110-4. [Medline].

  37. Mehr S, Kakakios A, Frith K, Kemp AS. Food protein-induced enterocolitis syndrome: 16-year experience. Pediatrics. Mar 2009;123(3):e459-64. [Medline].

  38. Murch S. Food allergies. In: Guandalini S. Ed. Textbook of pediatric gastroenterology and nutrition. London: Taylor & Francis; 2004.

  39. Niggemann B, Beyer K. Pitfalls in double-blind, placebo-controlled oral food challenges. Allergy. Jul 2007;62(7):729-32. [Medline].

  40. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med. Aug 26 2004;351(9):940-1. [Medline].

  41. Novembre E, Vierucci A. Milk allergy/intolerance and atopic dermatitis in infancy and childhood. Allergy. 2001;56 Suppl 67:105-8. [Medline].

  42. Osborn DA, Sinn J. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database Syst Rev. 2003;CD003664. [Medline].

  43. Sampson HA, Anderson JA. Summary and recommendations: Classification of gastrointestinal manifestations due to immunologic reactions to foods in infants and young children. J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S87-94. [Medline].

  44. Sicherer SH. Food protein-induced enterocolitis syndrome: clinical perspectives. J Pediatr Gastroenterol Nutr. 2000;30 Suppl:S45-9. [Medline].

  45. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr. May 2006;42(5):454-75. [Medline].

  46. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. Jan 2007;119(1):184-91. [Medline].

  47. Tlaskalova-Hogenova H, Tuckova L, Lodinova-Zadnikova R, et al. Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol. Jun 2002;128(2):77-89. [Medline].

Further Reading

Keywords

protein intolerance, food allergy, food-protein intolerance, food protein intolerance, food-protein allergy, cow's milk intolerance, cow's milk allergy, egg intolerance, egg allergy, soy intolerance, soy allergy, cow's milk protein, food allergens, immunoglobulin E–mediated pathogenesis, asthma, gastroenteritis, eosinophilic gastroenteritis, enterocolitis syndrome, cow's milk enteropathy, malabsorption syndrome, growth failure, hypoalbuminemia, proctocolitis syndrome, urticaria, angioedema, pollen allergy, oral allergy syndrome, GI anaphylaxis, esophageal eosinophilia, allergic esophagitis, chronic esophagitis, esophageal strictures, eosinophilic gastritis, celiac disease, protein-losing enteropathy, infantile colic, atopic dermatitis, oral aphthae, pyloric stenosis, bowel edema, bowel obstruction, treatment, diagnosis

Contributor Information and Disclosures

Author

Agostino Nocerino, MD, PhD, Chief of Pediatric Oncology, Department of Pediatrics, University of Udine, Italy
Agostino Nocerino, MD, PhD is a member of the following medical societies: American Society of Pediatric Hematology/Oncology
Disclosure: Nothing to disclose.

Coauthor(s)

Stefano Guandalini, MD, Director, University of Chicago Celiac Disease Program, Section Chief of Gastroenterology, Hepatology and Nutrition; Professor, Department of Pediatrics, University of Chicago Comer Children's Hospital
Stefano Guandalini, MD is a member of the following medical societies: American Gastroenterological Association, European Society for Paediatric Gastroenterology, Hepatology & Nutrition, and North American Society for Pediatric Gastroenterology and Nutrition
Disclosure: Nothing to disclose.

Medical Editor

Chris A Liacouras, MD, Director of Pediatric Endoscopy, Department of Pediatrics, Division of Gastroenterology and Nutrition, Associate Professor, Children's Hospital of Philadelphia and University of Pennsylvania
Chris A Liacouras, MD is a member of the following medical societies: American Gastroenterological Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

David A Piccoli, MD, Chief of Pediatric Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia; Professor, University of Pennsylvania School of Medicine
David A Piccoli, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American Gastroenterological Association, and North American Society for Pediatric Gastroenterology and Nutrition
Disclosure: Nothing to disclose.

CME Editor

Steven M Schwarz, MD, FAAP, FACN, AGAF, Professor of Pediatrics, Children's Hospital at Downstate, SUNY-Downstate Medical Center
Steven M Schwarz, MD, FAAP, FACN, AGAF is a member of the following medical societies: American Academy of Pediatrics, American College of Nutrition, American College of Physician Executives, American Gastroenterological Association, American Pediatric Society, Gastroenterology Research Group, New York Academy of Medicine, North American Society for Pediatric Gastroenterology and Nutrition, and Society for Pediatric Research
Disclosure: TAP Pharmaceuticals Honoraria Speaking and teaching; Curemark, LLC Consulting fee Board membership; Centocor, Inc. Grant/research funds Independent contractor

Chief Editor

Carmen Cuffari, MD, Associate Professor, Department of Pediatrics, Division of Gastroenterology/Nutrition, Johns Hopkins University School of Medicine
Carmen Cuffari, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.